Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + S-1 + Cisplatin in Advanced Gastric Cancer
NCT01388790Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Jun 2011
- Primary completion
- Aug 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Merck KGaA. Started Jun 2011; status: completed.
02
Drugs
KL-140
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01388790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388790.